Research & Development
ImmuneHealth develops research programmes in collaboration with pharmaceutical industry, biotech companies, public health institutions and academic laboratories to assess the safety and the efficacy of medical interventions targeting the immune system.
As our understanding of the immune system is rapidly evolving, increasingly sophisticated interventions targeting the immune system are developed. The monitoring of the efficacy and the safety of these new interventions requires the development of new biomarkers and validated assays.
To monitor the efficacy and the safety of medical interventions targeting the immune system including vaccines and other biopharmaceuticals, ImmuneHealth has built a multidisciplinary structure integrating immunology, clinical medicine and epidemiology. In order to meet societal health expectations and satisfy regulatory requirements, Immune Health works under high quality standards.
The research programmes developed by ImmuneHealth focus on to the discovery and the validation of immunological biomarkers. This knowledge enables us to provide cutting-edge epidemiological, clinical and laboratory services for clinical research. Bridging the gap between fundamental and applied research, ImmuneHealth translates immunology into medicine.
